BTIG Reiterates Buy on Biohaven, Maintains $24 Price Target
Portfolio Pulse from Benzinga Newsdesk
BTIG analyst Thomas Shrader has reiterated a Buy rating on Biohaven (NYSE:BHVN) and maintained a $24 price target.
June 06, 2023 | 9:12 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BTIG analyst Thomas Shrader reiterated a Buy rating on Biohaven (NYSE:BHVN) and maintained a $24 price target.
The Buy rating and maintained price target by BTIG analyst Thomas Shrader indicates a positive outlook for Biohaven's stock. This news is directly related to BHVN and is important for investors as it suggests potential growth in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100